Clinical features and survival of 338 multiple myeloma patients treated with hematopoietic stem cell transplantation or conventional chemotherapy.

about

Clinical features and survival of 338 multiple myeloma patients treated with hematopoietic stem cell transplantation or conventional chemotherapy.

Item

http://www.wikidata.org/entity/Q40719473

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Clinical features and survival ...... or conventional chemotherapy.

@en

type

Item

label

Clinical features and survival ...... or conventional chemotherapy.

@en

prefLabel

Clinical features and survival ...... or conventional chemotherapy.

@en

P1476

Clinical features and survival ...... or conventional chemotherapy.

@en

P2093

Alfons Soler

http://www.w3.org/2001/XMLSchema#string

Alicia Bailen Garcia

http://www.w3.org/2001/XMLSchema#string

Asunción Echeveste Gutierrez

http://www.w3.org/2001/XMLSchema#string

Gemma Ramirez

http://www.w3.org/2001/XMLSchema#string

Inmaculada Castillo

http://www.w3.org/2001/XMLSchema#string

Jose Baquero

http://www.w3.org/2001/XMLSchema#string

Jose Mayans

http://www.w3.org/2001/XMLSchema#string

Ma Carmen Menchaca Echevarria

http://www.w3.org/2001/XMLSchema#string

Ma Dolores Lopez Garcia-Carreño

http://www.w3.org/2001/XMLSchema#string

Ma Sol Durán

http://www.w3.org/2001/XMLSchema#string

P2860

Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients.

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma.

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.

International uniform response criteria for multiple myeloma.

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant.

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.

Review of 1027 patients with newly diagnosed multiple myeloma.

Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results.

IMWG consensus on maintenance therapy in multiple myeloma.

Improved survival in multiple myeloma and the impact of novel therapies.

P304

417-424

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/EJH.12611

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26190662

http://www.w3.org/2001/XMLSchema#string